Stay updated with breaking news from Chromium Controller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quarterly Results Earnings per share rose 186.96% over the past year to $0.66, which beat the estimate of $0.50. Revenue of $231,200,000 higher by 34.42% from the same period last year, which missed the estimate of $232,000,000. Guidance 10x Genomics hasn't issued any revenue guidance for the time being. How To Listen To The Conference Call Date: May 13, 2021
In this episode of Industry Focus: Wildcard, Motley Fool Analyst Maria Gallagher joins host Emily Flippen to discuss the prospects for 10x Genomics (NASDAQ:TXG), a healthcare tech company looking to reform the way researchers discover single-cell gene expression. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video. This video was recorded on April 21, 2021. Emily Flippen: Welcome to Industry Focus. Today is Wednesday, April 21st, a...
Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis Michael David Brügger , Contributed equally to this work with: Michael David Brügger, Tomas Valenta, Hassan Fazilaty Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing Affiliation Department of Molecular Life Sciences, University of Zurich, Switzerland Roles Conceptualization, ...